Is procalcitonin-guided antimicrobial use cost-effective in adult patients with suspected bacterial infection and sepsis? (Q41393065)

30 September 2017

title

Is procalcitonin-guided antimicrobial use cost-effective in adult patients with suspected bacterial infection and sepsis? (English)

1 reference

30 September 2017

0 references

Michelle Harrison

1

1 reference

30 September 2017

Curtis D Collins

series ordinal

2

1 reference

30 September 2017

publication date

1 March 2015

1 reference

Infection Control and Hospital Epidemiology

30 September 2017

published in

1 reference

30 September 2017

volume

36

1 reference

30 September 2017

issue

3

1 reference

30 September 2017

page(s)

265-272

1 reference

Effectiveness and safety of procalcitonin-guided antibiotic therapy in lower respiratory tract infections in "real life": an international, multicenter poststudy survey (ProREAL).

30 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1017%2FICE.2014.60

Use of procalcitonin to shorten antibiotic treatment duration in septic patients: a randomized trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FICE.2014.60

A systematic review and meta-analysis of utility-based quality of life in chronic kidney disease treatments

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FICE.2014.60

Preference-based quality of life of patients on renal replacement therapy: a systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FICE.2014.60

Cost-effectiveness analysis evaluating fidaxomicin versus oral vancomycin for the treatment of Clostridium difficile infection in the United States.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FICE.2014.60

Cost-effectiveness of drotrecogin alfa (activated) in the treatment of severe sepsis

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FICE.2014.60

Clinical and economic impact of procalcitonin to shorten antimicrobial therapy in septic patients with proven bacterial infection in an intensive care setting

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FICE.2014.60

Procalcitonin for reduced antibiotic exposure in the critical care setting: a systematic review and an economic evaluation

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FICE.2014.60

Cost-effectiveness of procalcitonin-guided antibiotic use in community acquired pneumonia

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FICE.2014.60

Procalcitonin-guided antibiotic therapy: a systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FICE.2014.60

Effect of antibiotic stewardship programmes on Clostridium difficile incidence: a systematic review and meta-analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FICE.2014.60

Procalcitonin as a diagnostic test for sepsis in critically ill adults and after surgery or trauma: a systematic review and meta-analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FICE.2014.60

Procalcitonin as a diagnostic marker for sepsis: a systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FICE.2014.60

Acute kidney injury, mortality, length of stay, and costs in hospitalized patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FICE.2014.60

Systematic review and meta-analysis of vancomycin-induced nephrotoxicity associated with dosing schedules that maintain troughs between 15 and 20 milligrams per liter

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FICE.2014.60

Incidence of nephrotoxicity and association with vancomycin use in intensive care unit patients with pneumonia: retrospective analysis of the IMPACT-HAP Database.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FICE.2014.60

Prevention of vancomycin induced nephrotoxicity: a review of preclinical data

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FICE.2014.60

Comparison of 8 vs 15 days of antibiotic therapy for ventilator-associated pneumonia in adults: a randomized trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FICE.2014.60

Surviving sepsis campaign: international guidelines for management of severe sepsis and septic shock: 2012

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FICE.2014.60

Clinical and economic outcomes from a community hospital's antimicrobial stewardship program

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FICE.2014.60

Using procalcitonin-guided algorithms to improve antimicrobial therapy in ICU patients with respiratory infections and sepsis

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FICE.2014.60

Use of procalcitonin to reduce patients' exposure to antibiotics in intensive care units (PRORATA trial): a multicentre randomised controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FICE.2014.60

Procalcitonin-guided interventions against infections to increase early appropriate antibiotics and improve survival in the intensive care unit: a randomized trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FICE.2014.60

Procalcitonin for reduced antibiotic exposure in ventilator-associated pneumonia: a randomised study

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FICE.2014.60

Procalcitonin (PCT)-guided algorithm reduces length of antibiotic treatment in surgical intensive care patients with severe sepsis: results of a prospective randomized study

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FICE.2014.60

Procalcitonin-guided therapy in intensive care unit patients with severe sepsis and septic shock--a systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FICE.2014.60

Procalcitonin to guide duration of antibiotic therapy in intensive care patients: a randomized prospective controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FICE.2014.60

An ESICM systematic review and meta-analysis of procalcitonin-guided antibiotic therapy algorithms in adult critically ill patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FICE.2014.60

Procalcitonin-guided algorithm to reduce length of antibiotic therapy in patients with severe sepsis and septic shock

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FICE.2014.60

Epidemiology of severe sepsis in the United States: analysis of incidence, outcome, and associated costs of care

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FICE.2014.60

Comparison of the incidence of vancomycin-induced nephrotoxicity in hospitalized patients with and without concomitant piperacillin-tazobactam

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FICE.2014.60

inferred from DOI database lookup

7 January 2021

based on heuristic

Cost-effectiveness of procalcitonin-guided antibiotic therapy for outpatient management of acute respiratory tract infections in adults

1 reference

https://api.crossref.org/works/10.1017%2FICE.2014.60

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1017/ICE.2014.60

1 reference

30 September 2017

1 reference